Category: Joint ventures/collaborations
-
Precision Microbial Resistance Joint Venture Formed
Biotech, pharma, and diagnostics companies are forming a new business to design precision diagnostics and treatments for drug-resistant microbes.
-
Diagnostics Companies Partner on Monkeypox Test
Two developers of tests for infectious diseases are collaborating on a molecular test to detect monkeypox, an emerging international public health concern.
-
Walgreens to Aid Recruitment for Clinical Trials
A retail drugstore chain is offering its store locations and online facilities to help recruit a more diverse patient population for clinical trials.
-
Digital Biomarkers Reveal Alzheimer’s Gender Differences
A study of people with and without Alzheimer’s disease found differences between women and men in their state of cognitive decline with data from mobile devices.
-
Companies Partner on Optimal Parkinson’s Drug Delivery
Two companies are developing a system to identify optimal times for people with Parkinson’s disease to take their symptom-reducing medications.
-
Sites Revealed for Lung Cancer Precision Diagnostic Trial
The first sites are selected for a study testing people with suspected lung tumors for cancer-causing mutations, to help decide on personalized treatments for their disease.
-
Trial Demonstrates 3-D Printed Ear Tissue Implant
A patient in a clinical trial received an implant made of three-dimensional printed tissue to replace a deformed ear caused by microtia, a congenital condition.
-
Biobank Study to Assess Obesity Types, Genetics
A study is now enrolling individuals to better understand different types of obesity, as well as genetics and other factors behind various obesity conditions.
-
Addiction Therapy, VR Companies Partner on Veteran PTSD
A developer of addiction therapies and virtual reality software company are collaborating on help for veterans suffering from post-traumatic stress disorder.
-
Venture Investor Funds Cell Therapy Targeting Tech
A venture capital company is funding biomedical engineering research to improve the reach and targeting of cell therapies to more diseases.